Dehydrolithocholic acid–FBW7–c-Jun signaling in CD8⁺ T cell dysfunction in colorectal cancer
Abstract Gut microbiota-derived bile acids can influence mucosal immunity, but their effects on antitumor CD8⁺ T cells in colorectal cancer (CRC) are not well defined. Targeted fecal bile-acid profiling identified dehydrolithocholic acid (DHLCA) as enriched in treatment-naive patients with CRC and associated with more advanced clinicopathologic features. In syngeneic tumor models, oral DHLCA accelerated tumor growth, whereas this effect was no longer evident after CD8⁺ T cell depletion. In primary mouse CD8⁺ T cells, DHLCA reduced proliferation, IFN-γ and GzmB production, and antigen-specific tumor-cell killing; activated human CD8⁺ T cells showed changes in the same direction. DHLCA lowered both Jun transcript abundance and c-Jun protein availability. Cycloheximide chase, proteasome inhibition, and immunoprecipitation experiments further showed faster c-Jun turnover together with increased FBW7-c-Jun association and c-Jun-associated ubiquitination. Loss of c-Jun was accompanied by reduced AP-1 activity, lower c-Jun occupancy at Gzmb and Ifng regulatory regions, and weaker TRE-dependent reporter activity. Enforced c-Jun expression partially restored CD8⁺ T cell effector function and antitumor activity despite continued DHLCA exposure. DHLCA also weakened tumor control during PD-1 blockade. These results link a microbiota-associated bile acid to impaired CD8⁺ T cell function through coordinated RNA-level and post-translational regulation of c-Jun.
Authors
- Chuang Meng
- Xueyan Zhou (ORCID: https://orcid.org/0000-0002-2993-9842)
- Tianhong Li (ORCID: https://orcid.org/0000-0001-7422-3520)
- Jun Song (ORCID: https://orcid.org/0000-0002-6350-2695)
- Qianqian Duan
- HUANG Chuting
- Jingshan Tong (ORCID: https://orcid.org/0009-0006-6849-4790)
- lianyu liu
- Xuanzheng Zhou
- Qian Lu
Institutions
- Xuzhou Medical College (CN)
- Xuzhou Cancer Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11104418/v1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- preprint
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province